시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 임상시험 공급 및 물류 시장 보고서(2025년)
Clinical Trial Supply And Logistics Global Market Report 2025
상품코드 : 1824361
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,493,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,386,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,279,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

임상시험 공급 및 물류 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 연평균 복합 성장률(CAGR) 9.1%로 72억 2,000만 달러로 성장할 것으로 예상됩니다. 예측기간의 성장은 맞춤형 의료에 대한 수요 증가, 임상검사수 증가, 만성질환 유병률 상승, 환자 중심 임상검사에 대한 주목 증가, 가상검사 이용 증가 등으로 인한 것으로 예측됩니다. 예측기간의 주요 동향으로는 임상시험 공급 및 물류기업, 제약기업, 기타 이해관계자간의 전략적 제휴, 임상검사서비스 아웃소싱 증가, 지속적인 기술진보, 연구개발비 증가, 임상검사공급 엄격한 규제 준수 및 품질보증 등이 있습니다.

향후 5년간의 성장률을 9.1%로 예측한 것은 전회 예측으로부터 0.1%의 소폭 감소를 반영한 것입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세의 부과는 벨기에나 일본에서 수입되는 온도관리된 임상시험약(IMP) 시퍼 및 양방향 반응기술(IRT) 시스템의 비용을 상승시키고, 의약품의 안정성을 손상시키지 않고, 물류 비용을 상승시킬 수 있기 때문에 미국의 임상시험 업무를 혼란시킬 수 있습니다. 또한 상호 관세와 무역 긴장 증가와 제한으로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 더 광범위하게 영향을 받을 수 있습니다.

시험 약물 공급과 물류 시장의 예상 성장은 임상 검사 증가에 의해 촉진될 것으로 예측됩니다. 임상검사란 새로운 치료와 개입, 진단방법의 안전성과 효능을 평가하기 위해 인간을 대상으로 한 조사연구입니다. 임상시험 공급 및 물류는 생물학적 검체의 수집 및 운송, 시험용 의약품 및 키트의 제공, 허가 신청을 위한 전문 지식, 통관 절차, 그 외 필요한 구성 요소들이 포함됩니다. 필수 물품의 제공에 있어 핵심적인 역할을 합니다. 예를 들어 미국 국립의료도서관에 의한 임상검사의 등록기관인 ClinicalTrials.gov는 2023년 7월 시점에서 등록된 임상검사가 2022년 39만 9,499건에서 2023년 7월에는 43만 7,533건으로 증가하여 미국 50개 주와 221개국에 이르렀습니다. 이 중 14만 1,513개 검사(전체의 31%)가 미국에서 등록되었고, 244,707개 검사(전체의 53%)가 미국 이외의 지역에서 등록되었습니다. 따라서 임상검사수 증가가 임상시험 공급 및 물류시장 확대의 원동력이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

SHW
영문 목차

영문목차

Clinical trial supply and logistics involve the systematic process of ensuring the timely and cost-effective delivery of necessary supplies, equipment, and medications for the execution of a clinical study. This critical procedure is designed to facilitate the safe and efficient conduct of the study while emphasizing the reduction of costs.

The primary services provided in clinical trial supply and logistics encompass logistics and distribution, storage and retention, packaging labeling and blinding, manufacturing, comparator sourcing, and others. Logistics involves the strategic planning of moving commodities, while distribution executes the conveyance of these goods through careful planning. The different clinical trial phases include phase I, phase II, phase III, and phase IV, covering various areas such as oncology, cardiovascular diseases, respiratory diseases, CNS (central nervous system) and mental disorders, among others. These services are utilized by diverse end-users, including pharmaceuticals, biologicals, and medical devices.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The clinical trial supply and logistics market research report is one of a series of new reports from The Business Research Company that provides clinical trial supply and logistics market statistics, including clinical trial supply and logistics industry global market size, regional shares, competitors with a clinical trial supply and logistics market share, detailed clinical trial supply and logistics market segments, market trends and opportunities, and any further data you may need to thrive in the clinical trial supply and logistics industry. This clinical trial supply and logistics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The clinical trial supply and logistics market size has grown strongly in recent years. It will grow from $4.72 billion in 2024 to $5.1 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to increase in prevalence of chronic diseases, globalization of clinical trials, rise in demand for novel therapies, growth in number of clinical trials, improved healthcare infrastructure.

The clinical trial supply and logistics market size is expected to see strong growth in the next few years. It will grow to $7.22 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, growing number of clinical trials, rising prevalence of chronic diseases, increasing focus on patient-centric trials, increasing use of virtual trials. Major trends in the forecast period include strategic collaborations between clinical trial supply and logistics companies, pharmaceutical companies, and other stakeholders, rise in outsourcing of clinical trial services, ongoing technological advancements, increasing r&d expenditure, stringent regulatory compliance and quality assurance in clinical trial supply.

The forecast of 9.1% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. trial operations by increasing costs for temperature-controlled Investigational Medicinal Products(IMP) shippers and interactive response technology (IRT) systems imported from Belgium and Japan, potentially compromising drug stability and raising logistics costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated growth in the clinical trial supply and logistics market is expected to be propelled by the increasing number of clinical trials. These trials are research studies involving human participants to assess the safety and effectiveness of new medical treatments, interventions, or diagnostic procedures. Clinical trial supply and logistics play a pivotal role in delivering essential materials, including the collection and transportation of biological specimens, investigational drugs and kits, expertise for permit applications, customs clearance, and other necessary components to ensure the smooth execution of clinical trials. For instance, as of July 2023, ClinicalTrials.gov, a registry of clinical trials by the United States National Library of Medicine, reported an increase in registered clinical studies from 399,499 in 2022 to 437,533 by July 2023, spanning all 50 states in the United States and 221 countries. Of these, 141,513 studies (31% of the total) were registered in the U.S., while 244,707 studies (53% of the total) were registered in non-U.S. locations. Therefore, the growing number of clinical trials is a driving force behind the expansion of the clinical trial supply and logistics market.

Rising R&D expenditures are anticipated to drive the growth of the clinical trial supply and logistics market in the future. R&D expenditure refers to the financial resources dedicated by organizations to research and development activities aimed at fostering innovation and creating new products or services. The clinical trial supply and logistics market significantly supports increased R&D spending by providing efficient, reliable support in the management and distribution of investigational drugs, ensuring the smooth execution of clinical trials, and facilitating faster research and development processes. For instance, the European Commission, a Belgium-based government body, reported that the EU spent €363 billion ($391.27 billion) on R&D, with an R&D expenditure of 2.27% of GDP in 2022, up from 2.25% in 2021. Consequently, the growth in R&D expenditures is fueling the expansion of the clinical trial supply and logistics market.

Leading companies in the Clinical Trial Supply and Logistics Market are concentrating on technologies like temperature-controlled healthcare shipments to enhance the integrity and reliability of products during transit, ensuring regulatory compliance and better patient outcomes. Temperature-controlled healthcare shipments refer to transporting medical products, pharmaceuticals, and biological materials that require specific temperature conditions to preserve their safety and effectiveness. This process includes specialized packaging, monitoring systems, and logistics solutions to maintain the necessary temperature range throughout transit. For instance, in February 2024, FedEx Corporation, a US-based transportation company, launched the FedEx Life Science Center. This includes FedEx Customized Freight (FCF) for handling critical pharmaceutical shipments, with features such as top boarding priority, end-to-end custodial control, and dedicated delivery options to ensure product integrity. Customers also have access to FedEx Priority Alert Plus, which provides proactive monitoring for time-sensitive shipments and offers dry ice or gel pack replenishment options.

Major players in the clinical trial supply and logistics market are placing a strategic focus on product launches, such as the introduction of electronic data capture platforms, to reshape the landscape of clinical research. An electronic data capture platform is a digital system that efficiently collects, manages, and stores clinical trial data in electronic format, enhancing the accuracy, security, and speed of the data capture process. For instance, in March 2023, Cloudbyz, a leading provider of unified clinical trial management solutions based in the U.S., unveiled EDC 2.0, a groundbreaking platform. Distinguished by features such as a user-friendly interface, advanced data security, intelligent data validation, real-time monitoring, analytics, and compliance with international regulatory standards, this product launch is highly significant in streamlining data management processes, reducing errors, and expediting regulatory approvals, ultimately enhancing efficiency in research endeavors.

In October 2022, Myonex, a clinical trial supply company based in the U.S., acquired the clinical trial supply and drug wholesale businesses from Hubertus Apotheke for an undisclosed amount. This strategic acquisition is anticipated to bolster Myonex's presence throughout the European Union in the field of clinical trial supply. Hubertus Apotheke, headquartered in Germany, is a provider of a diverse range of pharmaceuticals and medical devices.

Major companies operating in the clinical trial supply and logistics market include United Parcel Service, DHL Group, FedEx Corporation, Thermo Fisher Scientific Inc., IQVIA, ICON plc, Eurofins Scientific, Catalent Inc., Intertek Group plc, Parexel International Corporation, UDG Healthcare PLC., Almac Group, World Courier, Piramal Pharma Solutions, Sharp Clinical Services Ltd., Clinigen Group, PCI Pharma Services, Movianto Group, Cold Chain Technologies, Biocair International Limited, QuickSTAT, Wasdell Group, Klifo A/S, TrakCel, Packaging Coordinators Inc., Biotec Services International Limited, Proventa International, Inceptua Group

North America was the largest region in the clinical trial supply and logistics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial supply and logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the clinical trial supply and logistics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The clinical trial supply and logistics market includes revenues earned by entities by providing services such as clinical supply planning, import and export compliance, inventory management, packaging services, and real-time track and trace and delivery. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Trial Supply And Logistics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical trial supply and logistics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for clinical trial supply and logistics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The clinical trial supply and logistics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Clinical Trial Supply And Logistics Market Characteristics

3. Clinical Trial Supply And Logistics Market Trends And Strategies

4. Clinical Trial Supply And Logistics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Clinical Trial Supply And Logistics Growth Analysis And Strategic Analysis Framework

6. Clinical Trial Supply And Logistics Market Segmentation

7. Clinical Trial Supply And Logistics Market Regional And Country Analysis

8. Asia-Pacific Clinical Trial Supply And Logistics Market

9. China Clinical Trial Supply And Logistics Market

10. India Clinical Trial Supply And Logistics Market

11. Japan Clinical Trial Supply And Logistics Market

12. Australia Clinical Trial Supply And Logistics Market

13. Indonesia Clinical Trial Supply And Logistics Market

14. South Korea Clinical Trial Supply And Logistics Market

15. Western Europe Clinical Trial Supply And Logistics Market

16. UK Clinical Trial Supply And Logistics Market

17. Germany Clinical Trial Supply And Logistics Market

18. France Clinical Trial Supply And Logistics Market

19. Italy Clinical Trial Supply And Logistics Market

20. Spain Clinical Trial Supply And Logistics Market

21. Eastern Europe Clinical Trial Supply And Logistics Market

22. Russia Clinical Trial Supply And Logistics Market

23. North America Clinical Trial Supply And Logistics Market

24. USA Clinical Trial Supply And Logistics Market

25. Canada Clinical Trial Supply And Logistics Market

26. South America Clinical Trial Supply And Logistics Market

27. Brazil Clinical Trial Supply And Logistics Market

28. Middle East Clinical Trial Supply And Logistics Market

29. Africa Clinical Trial Supply And Logistics Market

30. Clinical Trial Supply And Logistics Market Competitive Landscape And Company Profiles

31. Clinical Trial Supply And Logistics Market Other Major And Innovative Companies

32. Global Clinical Trial Supply And Logistics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Clinical Trial Supply And Logistics Market

34. Recent Developments In The Clinical Trial Supply And Logistics Market

35. Clinical Trial Supply And Logistics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기